AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15671428
Drug: GIK infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GIK infusion for 24 hours plus usual care (n = 10,091)
Trial: 10585975
Drug: Hydrocortisone treatment
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone treatment (1 mg/kg/day for 9 days followed by 0.5 mg/kg/day for 3 days)
Trial: 1832261
Drug: Glycopyrrolate (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate (7 micrograms.kg‐1, single dose)
Trial: 6619271
Drug: Domperidone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (10 mg, iv) administered at 1100 h
Trial: 6619271
Drug: Domperidone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (10 mg, iv) administered at 2300 h
Trial: 6376722
Drug: melphalan (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: melphalan (8 mg/m2 perorally for four days) and prednisone (40 mg/m2 perorally for seven days, both every four weeks)
Trial: 10571355
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia plus 0.5 ml intracameral balanced salt solution
Trial: 1859055
Drug: Oral killed
RxNorm normalized name: Hongo Killer
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral killed Haemophilus influenzae vaccine
Trial: 6138009
Drug: Buspirone hydrochloride
RxNorm normalized name: Buspirone Hydrochloride
DrugBank: Buspirone (DB00490)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buspirone hydrochloride 30 mg
Trial: 6138009
Drug: Buspirone hydrochloride
RxNorm normalized name: Buspirone Hydrochloride
DrugBank: Buspirone (DB00490)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buspirone hydrochloride 60 mg
Trial: 6138009
Drug: Buspirone hydrochloride
RxNorm normalized name: Buspirone Hydrochloride
DrugBank: Buspirone (DB00490)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buspirone hydrochloride 90 mg
Trial: 6138009
Drug: Buspirone hydrochloride
RxNorm normalized name: Buspirone Hydrochloride
DrugBank: Buspirone (DB00490)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buspirone hydrochloride (30, 60, 90 mg)
Trial: 31290965
Drug: Esketamine 56
RxNorm normalized name: ESKETAMINE
DrugBank: Esketamine (DB11823)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Esketamine 56 mg plus oral antidepressant
Trial: 31290965
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus oral antidepressant
Trial: 28816150
Drug: Ipilimumab 3
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab 3 mg/kg with WBRT (n=5)
Trial: 28816150
Drug: Ipilimumab 10
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab 10 mg/kg with SRS (n=11)
Trial: 25413313
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) in 27 patients with LVI-positive tumors.
Trial: 16971315
Drug: Azithromycin 500
RxNorm normalized name: azithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 500 mg for 3 consecutive days a week for 1 month, then 250 mg every other day for 2 months
Trial: 15179210
Drug: Beta-blocker (Metoprolol)
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker (Metoprolol)
Trial: 11722956
Drug: Methionine intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methionine intake of 0 mg x kg(‐1) x d(‐1)
Trial: 11722956
Drug: Methionine intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methionine intake of 6.5 mg x kg(‐1) x d(‐1)
Trial: 21570870
Drug: Batroxobin plus
RxNorm normalized name: batroxobin
DrugBank: Batroxobin (DB09005)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Batroxobin plus aspirin (5 IU every other day for six doses)
Trial: 21570870
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (100 mg/d)
Trial: 21570870
Drug: Batroxobin plus
RxNorm normalized name: batroxobin
DrugBank: Batroxobin (DB09005)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Batroxobin plus aspirin
Trial: 11180027
Drug: 10 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/70 kg of morphine
Trial: 11180027
Drug: 3.3 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.3 mg/70 kg of M6G
Trial: 11180027
Drug: 30.6 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30.6 mg/70 kg of M3G
Trial: 11180027
Drug: 30.6 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30.6 mg/70 kg of M3G with 10 mg/70 kg of morphine
Trial: 9382506
Drug: Postoperative complications
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative complications in radiation therapy group
Trial: 8808186
Drug: Intravenous cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclophosphamide (CTX)
Trial: 21099157
Drug: Etching with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etching with 10% citric acid‐3% FeCl(3) solution
Trial: 18398348
Drug: Ramipril, 10
RxNorm normalized name: Ramipril, 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril, 10 mg once daily for 24 weeks
Trial: 14570950
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg gefitinib
Trial: 14570950
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg gefitinib
Trial: 14570950
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses of gefitinib
Trial: 9598255
Drug: Propofol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2.5 mg.kg‐1)
Trial: 8678385
Drug: ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ipratropium bromide nasal spray 0.06% (two 42-micrograms sprays per nostril)
Trial: 8678385
Drug: ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ipratropium bromide nasal spray 0.06%
Trial: 30842084
Drug: Hydroxychloroquine (HCQ)
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine (HCQ) treatment for more than 5 years
Trial: 29342952
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy (STreSS)
Trial: 27724992
Drug: Oral spray
RxNorm normalized name: Oral Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral spray vitamin D3 (3000 IU daily for 4 weeks)
Trial: 27724992
Drug: Capsule vitamin
RxNorm normalized name: vitamin A Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule vitamin D3 (3000 IU daily for 4 weeks)
Trial: 18441679
Drug: Fenspiride in
RxNorm normalized name: fenspiride
DrugBank: Fenspiride (DB08979)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenspiride in combination with broncholytic drugs for 6 months
Trial: 16800987
Drug: combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: combination of LDL and UDA (LDL + UDA)
Trial: 21262858
Drug: donepezil 5
RxNorm normalized name: donepezil 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: donepezil 5 mg
Trial: 21262858
Drug: donepezil 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: donepezil 7.5 mg
Trial: 7839518
Drug: Vitaria oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitaria oxygen delivery system (75 mg sodium carbonate powder, max flow of 1 l/min for 15 minutes)
Trial: 3147338
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of nitroglycerin (both TNL and ND)
Trial: 26376805
Drug: Paroxetine (20-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20-40 mg)
Trial: 10795116
Drug: Amitriptyline (75-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (75-150 mg)
Trial: 1601756
Drug: Cefpirome 2
RxNorm normalized name: Cefpirome
DrugBank: Cefpirome (DB13682)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefpirome 2 g intravenously
Trial: 6527751
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg of liquid haloperidol daily
Trial: 22325048
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg/week
Trial: 21970137
Drug: Midazolam 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.05 mg/kg (group M)
Trial: 21970137
Drug: Propofol 1
RxNorm normalized name: propofol 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1 mg/kg (group P)
Trial: 11449608
Drug: Both medications
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both medications
Trial: 16916538
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg MPH
Trial: 16916538
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg MPH
Trial: 16916538
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg cocaine
Trial: 3526085
Drug: Tamoxifen (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (10 mg orally bid)
Trial: 1090132
Drug: Bendroflumethiazide, 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendroflumethiazide, 5 mg plus Bumetanide, 4 mg
Trial: 1090132
Drug: Bumetanide, 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bumetanide, 4 mg
Trial: 1090132
Drug: Bendroflumethiazide, 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendroflumethiazide, 5 mg plus Spironolactone, 100 mg
Trial: 23816410
Drug: Anti-tuberculous therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-tuberculous therapy for 8 months
Trial: 14686230
Drug: Valganciclovir 900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valganciclovir 900 mg once daily
Trial: 11713941
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon administered daily
Trial: 11713941
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon administered three times weekly
Trial: 8213711
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid 1000 mg/day
Trial: 16753240
Drug: Quadrivalent HPV
RxNorm normalized name: HPV, quadrivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent HPV (Types 6/11/16/18) L1 virus‐like particle (VLP) vaccine
Trial: 26639477
Drug: Placebo formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo formulations
Trial: 2870277
Drug: Different treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different treatments received by the first 130 patients
Trial: 2870277
Drug: Different treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different treatments received by the second group of 142 patients
Trial: 20083627
Drug: High-dose losartan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose losartan (150 mg)
Trial: 15235144
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation therapy
Trial: 19260630
Drug: Group A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A: 20 ml normal saline preincisional infiltration and 20 ml R0, 25% intraperitoneal
Trial: 19260630
Drug: Group B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B: 20 ml R0, 0.25% preincisional parietal and 20 ml normal saline intraperitoneal
Trial: 12543742
Drug: Lignocaine 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine 2% gel
Trial: 10389775
Drug: Clonidine 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 3 microg/kg and famotidine 20 mg orally with isoflurane anesthesia
Trial: 8537982
Drug: High-dose wheat
RxNorm normalized name: WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose wheat bran fiber (13.5 g/day)
Trial: 8537982
Drug: High-dose calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose calcium carbonate (1500 mg/day)
Trial: 11791035
Drug: ARB alone
RxNorm normalized name: revakinagene taroretcel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARB alone (irbesartan 150 mg/day)
Trial: 11791035
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ACEI + ARB
Trial: 16143731
Drug: IPSRT (Interpersonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IPSRT (Interpersonal and Social Rhythm Therapy)
Trial: 19249750
Drug: Varenicline (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline (2 mg/day)
Trial: 15958334
Drug: Cefazolin (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin (single dose) prior to TACE
Trial: 11281486
Drug: No prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No prophylactic antibiotics (NONE group)
Trial: 8208596
Drug: Exosurf Neonatal
RxNorm normalized name: Exosurf Neonatal Powder for Intratracheal Suspension
DrugBank: Colfosceril palmitate (DB09114)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exosurf Neonatal (5 mL/kg)
Trial: 8208596
Drug: Survanta (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Survanta (4 mL/kg)
Trial: 2645569
Drug: Taurine supplementation
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine supplementation (45 mg/L)
Trial: 2645569
Drug: Control (less
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (less than 5 mg/L taurine)
Trial: 26824933
Drug: SFC 25/250 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SFC 25/250 μg with Mini Spacer
Trial: 26824933
Drug: SFC 25/250 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SFC 25/250 μg with Aerochamber
Trial: 24046993
Drug: Propofol (1-1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (1-1.5 mg/kg)
Trial: 17201701
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of major antiepileptic drugs (AEDs)
Trial: 17201701
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of major antiepileptic drugs (AEDs)
Trial: 2834746
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg itraconazole for 1 day
Trial: 2834746
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg itraconazole for 2 days
Trial: 31394945
Drug: Rational Emotive
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rational Emotive Behavior Therapy (REBT)
Trial: 17136583
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type B (BT‐B) intravesical injections (5000 MU, 1 ml, diluted to 20 mls with normal saline, injected in 10 different sites into the detrusor)
Trial: 11220879
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (ST)
Trial: 22703892
Drug: Oxycodone 10mg
RxNorm normalized name: OXYCODONE 10MG/ACETAMINOPHEN 300MG TAB
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone 10mg / Morphine 20mg
Trial: 22703892
Drug: Oxycodone 15mg
RxNorm normalized name: oxycodone hydrochloride 15 MG [Roxicodone]
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone 15mg / Morphine 30mg
Trial: 22703892
Drug: Oxycodone 20mg
RxNorm normalized name: oxycodone
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone 20mg / Morphine 40mg
Trial: 22703892
Drug: Morphine 20mg
RxNorm normalized name: MORPHINE 20MG/NALTREXONE 0.8MG SA CAP
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine 20mg and 30mg
Trial: 22703892
Drug: Morphine 40mg
RxNorm normalized name: morphine sulfate 40 MG
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine 40mg and Oxycodone (all doses)
Trial: 16961805
Drug: Lansoprazole group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole group: 7-day course of lansoprazole 30 mg, amoxicillin 750 mg, and metronidazole 250 mg, b.i.d.
Trial: 16961805
Drug: Famotidine group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine group: 7-day course of famotidine 40 mg, amoxicillin 750 mg, and metronidazole 250 mg, b.i.d.
Trial: 7963709
Drug: Zidovudine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine (200 mg every 4 h)
Trial: 7963709
Drug: Intermittent dideoxycytidine
RxNorm normalized name: deoxycytidine
DrugBank: 2'-Deoxycytidine (DB02594)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent dideoxycytidine (ddC) (0.03 mg/kg every 4 h)
Trial: 3307888
Drug: Placebo therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo therapy given in a similar treatment schedule
Trial: 31772064
Drug: High-flow nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow nasal cannula (HFNC) therapy (60 L/min) for 15 min
Trial: 31772064
Drug: Conventional oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional oxygen (O2) therapy for 15 min
Trial: 18419825
Drug: 5 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml/kg normal saline (Ns group, n = 32)
Trial: 18419825
Drug: 5 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml/kg 3.5% sodium chloride (Hs group, n = 30)
Trial: 18419825
Drug: 5 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml/kg 5% sodium bicarbonate (Sb group, n = 32)
Trial: 16768639
Drug: Risperidone (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (1.5 mg/day)
Trial: 22741619
Drug: Quetiapine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (200 mg/day)
Trial: 11530275
Drug: Olanzapine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (10 mg/day)
Trial: 11053917
Drug: Calcitriol 3
RxNorm normalized name: CALCITRIOL 3MCG/GM OINT,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol 3 microg/g ointment (twice daily)
Trial: 11053917
Drug: Dithranol cream
RxNorm normalized name: Zithranol
DrugBank: Anthralin (DB11157)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dithranol cream (0.25-2%, once daily for 30 min)
Trial: 9057430
Drug: 5-day treatment
RxNorm normalized name: 30 day Acne Treatment Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-day treatment with bismuth, metronidazole, and tetracycline
Trial: 9057430
Drug: 7-day treatment
RxNorm normalized name: Gyne-Lotrimin 1% 7-Day Treatment Vaginal Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day treatment with bismuth, metronidazole, and tetracycline
Trial: 21718474
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g methylprednisolone for three consecutive days
Trial: 11506100
Drug: 0.075 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.075 mg/kg cisatracurium
Trial: 8291370
Drug: High-dose methyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methyl prednisolone (HDMP) 10 mg/kg/day for 5 days i.v. (n = 10)
Trial: 8291370
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIG) 0.4 g/kg/day for 5 days (n = 10)
Trial: 8291370
Drug: Conventional-dose prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional-dose prednisone (CDP) 2 mg/kg/day for 4 weeks p.o. (n = 10)
Trial: 8291370
Drug: Vincristine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vincristine 1.5 mg/m2/week i.v. 4 doses (n = 4)
Trial: 8291370
Drug: IVIG 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG 0.4 g/kg/day for 5 days (n = 8)
Trial: 26060122
Drug: Therapy with
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy with glycoprotein IIb/IIIa inhibitors
Trial: 16815858
Drug: Everolimus 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 3.0 mg/day
Trial: 17181650
Drug: Everolimus 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 3.0 mg/day with basiliximab
Trial: 17181650
Drug: Everolimus 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 1.5 mg/day with basiliximab
Trial: 31037562
Drug: Everolimus (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus (both doses)
Trial: 11920260
Drug: MP (melphalan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MP (melphalan 9 mg/m2 p.o. and prednisone 60 mg/m2 days 1-4)